Conjunctiva vs. Sclera: Key Differences in Eye Anatomy

The conjunctiva and sclera sit right next to each other on the surface of the eye, but they are fundamentally different tissues with different jobs. The sclera is the tough, white, collagen-rich shell that gives the eyeball its shape and protects the structures inside it. The conjunctiva is the thin, transparent mucous membrane draped over the sclera’s front surface and lining the inner eyelids. Because the conjunctiva is see-through, what most people think of as “the white of the eye” is actually the sclera visible through the conjunctiva. That layered relationship is the source of a great deal of confusion, both for patients describing symptoms and for clinicians diagnosing them.

What Each Layer Is Made Of

The sclera is dense, fibrous connective tissue composed mostly of collagen and elastin fibers woven in irregular bundles. It forms a nearly complete sphere around the eye, interrupted only at the front by the cornea and at the back by a sieve-like plate where the optic nerve exits. The collagen fibers in a healthy sclera vary in diameter and are arranged in a somewhat random fashion, and that irregularity is what makes the tissue opaque and white. In osteogenesis imperfecta, a genetic condition affecting collagen, scleral fibers can be about half the normal width and far more uniform in size. That uniformity lets light pass through more easily, giving the sclera a characteristic blue tint rather than the usual white.

1PubMed. Histopathologic and electron-microscopic features of corneal and scleral collagen fibers in osteogenesis imperfecta type III

The conjunctiva, by contrast, is a delicate membrane only a few cell layers thick. It has a surface epithelium sitting on loose, vascular connective tissue called the stroma. Its structure is designed for flexibility and lubrication rather than strength. The conjunctiva also contains goblet cells that secrete mucins, which are essential for keeping the tear film stable and the eye surface hydrated. Both the cornea and conjunctiva produce membrane-spanning mucins, but the conjunctiva is the only surface tissue that also produces soluble mucins, the kind that spread across the tear film to lubricate the eye during blinking.

2PubMed Central. Tear film mucins: front line defenders of the ocular surface; comparison with airway and gastrointestinal tract mucins

Blood Supply and Why It Matters

One of the starkest differences between the two tissues is how much blood flows through them. The conjunctiva is richly vascular. Its blood supply comes from multiple sources: the marginal and peripheral tarsal arcades feed the eyelid-facing portions, while the anterior ciliary arteries supply the part covering the eyeball. A watershed zone where these two vascular systems overlap sits roughly three to four millimeters from the limbus, the border between the cornea and sclera.

3PubMed Central. Vascular supply of the eye: clinical anatomy – Section: Sclera, episclera, and conjunctiva

The sclera itself is relatively avascular. It gets some nutrition by diffusion from the episclera, a thin layer of tissue sitting between the sclera and the conjunctiva, and from the choroid underneath. Most of the visible blood vessels on the front of the eye actually belong to the conjunctival and episcleral plexuses rather than the sclera. In the conjunctival plexus, the majority of vessels are capillary-sized, while the episcleral plexus is dominated by venules.

4PubMed. Conjunctival and episcleral blood vessels are permeable to blood-borne horseradish peroxidase

The anterior ciliary arteries feed an episcleral arterial circle that has both superficial and deep components. This circle, which sits about four millimeters from the limbus, supplies blood to the conjunctiva, the episclera, the limbal arcades around the cornea, and arterioles heading into the iris. Where the superficial component is incomplete, deeper vessels step in to fill gaps.

5PubMed Central. Low dose fluorescein angiography of the conjunctiva and episclera

This difference in vascularity is why the conjunctiva can become bright red almost instantly when irritated: it has a dense network of tiny blood vessels that dilate quickly. The sclera, being nearly bloodless, does not redden on its own in the same way. When the deeper episcleral or scleral vessels become inflamed, the redness tends to look more violaceous or dusky rather than the bright fire-engine red of a simple conjunctival reaction.

Nerve Supply and Sensitivity

Both the conjunctiva and sclera are innervated, but their sensory profiles differ. Electrophysiology studies have identified several types of nerve fibers in both tissues, including ones that respond only to painful mechanical force (mechanonociceptors) and ones that respond to irritant chemicals and heat (polymodal nociceptors). The conjunctiva also has low-threshold mechanoreceptors and cold-sensitive neurons that likely mediate the sensations of touch and temperature you feel when wind blows across your open eye.

6Elsevier / Progress in Retinal and Eye Research. Neurobiology of ocular pain

In practical terms, the conjunctiva is more sensitive to everyday stimuli like a stray eyelash or a gust of cold air. The sclera’s innervation is more relevant when deeper inflammation strikes. Scleritis, for instance, produces a boring, aching pain that can radiate to the jaw or temple and often wakes people from sleep. That deep ache reflects the sclera’s nerve fibers signaling damage from within the wall of the eye, a qualitatively different experience from the gritty, stinging irritation of conjunctivitis.

Common Conditions and How to Tell Them Apart

When the front of someone’s eye turns red, the question of where the inflammation actually sits determines everything about how serious it is and what to do about it. The main possibilities are conjunctivitis (inflammation of the conjunctiva), episcleritis (inflammation of the episclera), and scleritis (inflammation of the sclera itself). Each looks and feels different, and the stakes climb sharply as you go deeper.

Conjunctivitis is overwhelmingly the most common of the three. It produces diffuse redness, tearing, and sometimes discharge. It can be caused by viruses, bacteria, allergies, or chemical irritants. It is usually self-limiting and rarely threatens vision. Episcleritis sits one layer deeper. It tends to produce a sector of redness rather than diffuse inflammation, with mild discomfort but not severe pain. It, too, usually resolves on its own or with mild treatment.

Scleritis is the one that demands attention. It can cause blindness through complications like scleral thinning or necrosis, corneal damage, and inflammation spreading to the inner eye.

7Elsevier / Experimental Eye Research. Current insights in the pathogenesis of scleritis The pathogenesis of scleritis remains poorly understood, partly because the disease is rare and partly because scleral tissue samples from living patients are hard to come by. The immune system appears to play a central role, with evidence pointing toward immune-mediated destruction of scleral collagen involving matrix metalloproteinases. Many cases of scleritis are associated with systemic autoimmune diseases like rheumatoid arthritis or granulomatosis with polyangiitis, making it an important red flag for internists as well as eye doctors.

Clinicians can distinguish episcleritis from scleritis at the bedside using phenylephrine drops. Phenylephrine constricts the superficial conjunctival and episcleral blood vessels. If the redness fades after the drop, the inflamed vessels are superficial, pointing to episcleritis. If the redness persists, the deeper scleral vessels are the source, and scleritis is more likely.

8PubMed Central. Is this a worrisome red eye? Episcleritis in the primary care setting

Pterygium and the Conjunctiva’s Vulnerability to UV Damage

A pterygium is a wing-shaped growth of fleshy tissue that starts in the conjunctiva and can creep onto the cornea. It is one of the most common conditions specific to the conjunctiva. Chronic exposure to ultraviolet radiation is thought to play a major role in its development, though chronic inflammation from other causes may also contribute. One distinctive feature of pterygia is their heavy vascularity, which is likely driven by the inflammatory process.

9Eye. Pathogenesis of pterygium

When pterygia grow large enough to affect vision or cause persistent irritation, surgical removal is the standard treatment. The conjunctiva’s ability to regenerate and be repositioned makes it a useful resource during these surgeries. Two common approaches involve either grafting a piece of the patient’s own conjunctiva from another part of the eye to cover the bare area, or creating a transposition flap from adjacent conjunctival tissue. Both techniques achieve low recurrence rates. In one comparative study, recurrence at six months was under five percent in both groups, but the transposition flap technique was significantly faster to perform, averaging about sixteen minutes compared to roughly twenty-two minutes for the autograft.

10Saudi Journal of Ophthalmology. Comparison of conjunctival autograft and conjunctival transposition flap techniques in primary pterygium surgery

The Jaundice Question

When a doctor checks you for jaundice, they look at “the whites of your eyes” for a yellowish tint. Medical textbooks and clinical shorthand often call this “scleral icterus,” but the term is misleading. Bilirubin, the pigment responsible for the yellow color, deposits primarily in the conjunctiva rather than in the sclera itself. The conjunctiva is rich in elastin, which has a high affinity for bilirubin. The sclera, being almost entirely collagen, does not take up bilirubin as readily. The correct term is “conjunctival icterus,” though “scleral icterus” remains deeply embedded in clinical parlance. For the patient, the distinction is academic in one sense: jaundice still looks yellow either way. But it matters anatomically, and it is a good example of how people conflate the two structures because the conjunctiva is transparent and the sclera is what you think you are looking at.

The Sclera as a Drug Delivery Route

One of the more surprising differences between these tissues has to do with pharmacology. The sclera is far more permeable to dissolved drugs than its tough appearance suggests. Its collagen fiber structure contains aqueous channels that allow molecules to diffuse through, and researchers have been exploring the transscleral route to deliver medications to the retina and choroid at the back of the eye. This approach could potentially spare patients from repeated injections directly into the vitreous cavity, which is currently the standard for treating conditions like macular degeneration.

In one study testing cisplatin delivery through the sclera using a collagen matrix, the drug achieved measurable concentrations in the vitreous humor within ninety minutes and in the choroid and retina at levels high enough to be therapeutically relevant, with detectable levels persisting for two weeks after a single subconjunctival injection.

11PubMed Central. Transscleral permeability and intraocular concentrations of cisplatin from a collagen matrix

The conjunctiva plays a role in this delivery strategy too, but in a different way. Subconjunctival injections place the drug depot between the conjunctiva and the sclera, essentially using the conjunctiva as a temporary reservoir and the sclera as the pathway to the interior of the eye. The conjunctiva’s own blood vessels can actually work against this approach by absorbing some of the drug into systemic circulation before it has a chance to cross the sclera. Researchers designing transscleral delivery systems have to account for this “conjunctival clearance” problem.

Blue Sclera and What It Reveals About Collagen

The sclera’s whiteness is such a reliable feature that changes in its color are clinically meaningful. In osteogenesis imperfecta, the collagen defect that causes brittle bones also affects the sclera. As mentioned earlier, scleral collagen fibers in people with this condition are narrower and more uniform than normal. Researchers have proposed that this uniformity is directly responsible for the blue appearance, because evenly spaced fibers transmit short-wavelength light (blue) more readily, making the dark choroid beneath the sclera partially visible.

12PubMed. Histopathologic and electron-microscopic features of corneal and scleral collagen fibers in osteogenesis imperfecta type III

This finding illustrates something important about the sclera: its opacity is not simply a matter of being thick. The arrangement and variability of collagen fiber diameters are what scatter light in all directions, producing the white appearance. When that variability is lost, even a sclera of reasonable thickness can become translucent. Blue sclerae can also appear in other connective tissue disorders and occasionally in healthy infants whose sclerae have not yet fully thickened, though in babies it is usually benign.

Scleritis and Systemic Disease

Scleritis deserves a closer look for the reader who wants to understand what can go wrong with the sclera specifically. It is uncommon but serious, and in a substantial proportion of cases it serves as a red flag for underlying autoimmune or inflammatory disease elsewhere in the body. The disease involves immune-mediated breakdown of scleral tissue, and timely treatment with immunosuppressive drugs can improve long-term outcomes significantly.

13PubMed Central. Scleritis

Careful history-taking matters here because the character of the pain is a major diagnostic clue. Unlike the itchy, sandy sensation of conjunctivitis or the mild tenderness of episcleritis, scleritis produces deep, constant pain that worsens with eye movement and can disturb sleep. If you describe that pattern to a doctor and they see deep redness that does not blanch with phenylephrine, the clinical picture points strongly toward scleritis and should trigger a workup for systemic inflammatory conditions.

How the Sclera Varies Across Species

The sclera is not unique to mammals, but its structure varies enormously across the animal kingdom. In humans and other mammals, the sclera is a purely fibrous shell. In birds and many reptiles, the sclera contains a cup of cartilage lining the retina plus a ring of small bony plates called scleral ossicles. Some sharks have calcified cartilage plates in their sclerae. In bony fish, most species have a ring of scleral cartilage, while a few have two actual bones.

14PubMed. Skeletons of the Eye: An Evolutionary and Developmental Perspective

These bony and cartilaginous reinforcements serve different purposes depending on the animal’s ecology. In diving birds, the scleral ossicle ring helps resist the pressure changes of plunging into water. In raptors, it helps maintain the elongated eye shape needed for extreme visual acuity. Humans lost these skeletal elements over evolutionary time, relying instead on intraocular pressure and the fibrous scleral wall alone to maintain eye shape. The conjunctiva, by contrast, shows far less dramatic variation across vertebrates; it remains a thin mucous membrane in essentially every species that has eyelids.

When Both Tissues Are Involved at Once

Many eye conditions do not neatly confine themselves to a single layer. Pterygium starts in the conjunctiva but can invade the cornea. Scleritis can extend forward to involve the episclera and conjunctiva or backward to affect the choroid. After eye surgery, both the conjunctival wound and the underlying scleral incision need to heal, and complications in one layer can affect the other. In glaucoma filtration surgery, for example, a small opening is created in the sclera to allow fluid drainage, and the conjunctiva is sutured over it to form a filtering bleb. The health and scarring behavior of the conjunctiva directly determines whether the surgery succeeds long-term.

The vascular supply reinforces this interconnection. Because the conjunctival and episcleral circulations share arterial sources and overlap in the same watershed zones, inflammation in one tissue readily recruits blood flow changes in its neighbor. The episclera, sitting between the two, acts as a vascular middleman. That anatomical intimacy is why clinical assessment of a red eye requires methodical evaluation of which layer is actually inflamed, since the surface appearance can be deceptive and the treatments for each condition differ substantially.

15PubMed Central. Vascular supply of the eye: clinical anatomy – Section: Sclera, episclera, and conjunctiva